This slide presentation summarizes a cytology case involving a 38-year-old female patient. A cervical smear shows atypical cells with dense, scanty cytoplasm and enlarged hyperchromatic nuclei throughout the smear. Background shows sheets of neutrophils, coccobacilli and hemorrhage. The specimen is categorized as an epithelial cell abnormality and interpreted as a high-grade squamous intra-epithelial lesion. Colposcopic examination is suggested. The presentation provides further details on cytology techniques, classifications of abnormal cervical cells, screening guidelines, and characteristics of low and high-grade squamous lesions.
This is a presentation on the topic of cytology of the breast, prepared by Dr Ashish Jawarkar, he is MD in pathology and a teacher at Parul institute of Medical sciences and research Vadodara.
This is a presentation on the topic of cytology of the breast, prepared by Dr Ashish Jawarkar, he is MD in pathology and a teacher at Parul institute of Medical sciences and research Vadodara.
Atlas on bethesda system for reporting cervical cytologyAshish Jawarkar
This is an atlas with more nearly 100 images, authentic taken from NCI web atlas. Useful to understand and report pap smears. The subject has been presented in a way which will help students reproduce in exams.
technique of preparing imprint smear# comparision with frozen sections# application and its role in thyroid ,paathyroid,breast,skin,head and neck and mucinous tumors# advantages and limitations
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist Lifecare Centre
HISTORY
Papanicolaou first reported in 1923 that cervical cancer or precancer could be detected by pap smear.
But it was only in 1943 that Pap test became accepted and widely used.
Many terminologies were used. Mostly numbers and term dysplasia. There were multiple poorly defined gradations which were poorly reproducible.
In 1988 the first Bethesda System workshop was convened to address the issue and to standardize the reporting of pap smear.
In 2001 a consensus was achieved and a terminology was recommended The 2001 Bethesda System (TBS)
Revision agreed upon in 2014
Atlas on bethesda system for reporting cervical cytologyAshish Jawarkar
This is an atlas with more nearly 100 images, authentic taken from NCI web atlas. Useful to understand and report pap smears. The subject has been presented in a way which will help students reproduce in exams.
technique of preparing imprint smear# comparision with frozen sections# application and its role in thyroid ,paathyroid,breast,skin,head and neck and mucinous tumors# advantages and limitations
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist Lifecare Centre
HISTORY
Papanicolaou first reported in 1923 that cervical cancer or precancer could be detected by pap smear.
But it was only in 1943 that Pap test became accepted and widely used.
Many terminologies were used. Mostly numbers and term dysplasia. There were multiple poorly defined gradations which were poorly reproducible.
In 1988 the first Bethesda System workshop was convened to address the issue and to standardize the reporting of pap smear.
In 2001 a consensus was achieved and a terminology was recommended The 2001 Bethesda System (TBS)
Revision agreed upon in 2014
Cervical screening is the process of detecting and removing abnormal tissue or cells in the cervix before cervical cancer develops. By aiming to detect and treat cervical neoplasia early on, cervical screening aims at secondary prevention of cervical cancer. Several screening methods for cervical cancer are the Pap test (also known as Pap smear or conventional cytology), liquid-based cytology, the HPV DNA testing and the visual inspection with acetic acid. Pap test and liquid-based cytology have been effective in diminishing incidence and mortality rates of cervical cancer in developed countries but not in developing countries.Prospective screening methods that can be used in low-resource areas in the developing countries are the HPV DNA testing and the visual inspection.
This is a presentation on most common applications of immunohistochemistry in breast lesions. Prepared by Dr Ashish Jawarkar, Assistant professor in pathology, Parul Institute of Medical sciences and research Vadodara
This is a journal article review of Multiplex chip protocol used for prostate biopsy. It also includes a modern concept of human molecular genetics called CRISPR-Cas9
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Single Pap-stained Cervical Smear of 38 years female
(Conventional cytology)
Smear shows superficial, intermediate, and parabasal
cells along with few endocervical cells.
Atypical cells are found arranged singly, in sheets and
in clusters throughout the smear.
These cells are round to oval (parabasal) in shape with
dense, scanty cytoplasm, enlarged hyperchromatic
nuclei, coarse chromatin and irregular nuclear rim
with high N : C ratio and inconspicuous nucleoli.
SLIDE PRESENTATION
2
3. Background shows sheets of neutrophils and
coccobacilli along with hemorrhage.
Necrosis and mitosis is not seen
SLIDE PRESENTATION
3
4. Specimen: Cervical smear
Adequacy: Satisfactory for evaluation; endocervical component
present
General Categorization*: Epithelial cell abnormality, squamous
Interpretation: High-grade squamous intra-epithelial lesion (HSIL)
Adjunctive Testing*: Not done in smear
Note*: Suggest colposcopic examination
* Optional to mention in Report.
SLIDE PRESENTATION
4
11. Columnar lining changes into
squamous in TZ
TZ is a dynamic point, keep on
changing. Move out towards
ectocervix during puberty,
pregnancy and pills. Move
inwards when hormonal
influences are absent like after
menopause.
CERVIX
11
12. BURDEN OF CERVICAL CANCER
WHO:
Cervical cancer is the second most common cancer in women living
in less developed regions with an estimated 570 000 new cases in
2018 (84% of the new cases worldwide).
In 2018, approximately 311 000 women died from cervical cancer;
more than 85% of these deaths occurring in low- and middle-
income countries.
High risk HPV: 16, 18, 31, 33, 35,39, 45, 51, 52, 56, 58, 59, 68, 69, 82
Low risk HPV: 6, 11, 40, 42, 43, 44, 54, 61, 72, 81
On average, 50% of HPV infections are cleared within 8 months and
90% are cleared within 2 years.
CERVICAL CANCER OVERALL BURDEN
12
14. HPV and cervical cancer
14
• Although HPV has been
firmly established as a
common cause of
cervical cancer, it is not
sufficient to cause
cancer.
• Host immune and co-
carcinogen exposure
influences the fate of
HPV and progression to
cancer.
17. United States Preventive Service Task Force
(USPSTF), 2018 recommends:
• Age to initiate: 21 years
• Age to discontinue: 65 years
• Between 21-29 years: Pap test every 3 years
• After 30 years: One of these methods:
• Pap test every 3 years
• hrHPV testing alone every 5 years
• Co-testing (Pap test and HPV testing) every 5 years
Routine Screening of patients
17
35. LSIL cervical cytologic specimens that contain a few cells that
are suspicious for but not diagnostic of HSIL are reported as
atypical squamous cells, cannot exclude a high-grade
squamous intraepithelial lesion(ASC-H). There was previously
no recommendation regarding how to report these.
Benign-appearing endometrial cells are reported only in
women ≥45 years. This is a change from Bethesda 2001, which
used an age threshold of ≥40 years.
Pages: 191 324
Images: 186 370
Bethesda 2014 vs 2001
35
36. 1. Description of specimen type and test requested –
cervical or vaginal sample, conventional Pap smear,
liquid-based cytology, and/or reflex human
papillomavirus (HPV) test.
2. A description of specimen adequacy
3. A general categorization (optional) – Negative,
epithelial cell abnormality, or other
4. An interpretation/result – Either the specimen is NILM
(although organisms and reactive changes may be
present) or there is an epithelial cell abnormality as
defined, or there is another finding(increased risk like
endometrial cells in women ≥45 years).
Bethesda 2014 Overview of Report
36
37. 5. A description of any ancillary testing or automated
review that was performed (eg. HPV, AutoPap)
6. Educational notes and suggestions by the pathologist
(optional)
Bethesda 2014 Overview of Report
37
40. 1. Cellularity >5000 (LBP), 8000-12000 (CP)
>2000: Low cellularity but satisfactory: Post-radiation, Post-TH vaginal)
2. Endocervical component
EC/TZ is not necessary for adequate specimen, only squamous
cellularity is needed
Adequate TZ requires at least 10 well preserved EC or squamous
metaplastic cells
No relation with further diagnosis with SIL
3. Obscuring factors (Blood, lubricants)
>75% of sq cells (not the slide area) : unsatisfactory
4. HPV testing on unsatisfactory specimen
HPV test could be falsely negative in unsatisfactory specimen
However, if HPV is positive in these specimen, follow up is still needed
ADEQUACY
40
41. ASC refers to cytologic changes suggestive of SIL, which
are qualitatively and quantitatively insufficient for
definite interpretation
Three essential features
1. Squamous differentiation
2. Increased ratio of nuclear to cytoplasmic area
3. Minimal nuclear hyperchromasia, chromatin
clumping, irregularity, smudging or multinucleation
ATYPICAL SQUAMOUS CELL
41
42. • Definition: cytological changes suggestive of LSIL that are
quantitatively and qualitatively insufficient for a definitive diagnosis
• CRITERIA
– Cells resemble superficial and intermediate squamous cells in size
and configuration
– Nuclei are approximately
2 and half to three times the area of the nucleus of a normal intermediate
squamous cell or twice the size of a squamous metaplastic cell nucleus.
– Slighlty increased N:C ratio
– Minimal nuclear hyperchromasia and irregularity of chromatin
distribution or nuclear shape
– Nuclear abnormalities associated with dense orangeophilic
cytoplasm (atypical parakeratosis)
ATYPICAL SQUAMOUS CELL -UNDETERMINED
SIGNIFICANCE (ASC-US)
42
46. • Definition: cytological changes suggestive of HSIL that are
quantitatively and qualitatively insufficient for a definitive diagnosis
• Patterns:
A. Small cells with high N:C Ratios (Atypical immature Metaplasia)
• Cells usually occur singly or in small fragments of less than 10
cells, occasionally in conventional smears, cells may stream in
mucus.
• Cells are size of metaplastic cells with nuclei that are about 1.5
to 2.5 times larger than normal
• N/C ratio may approximate that of HSIL
ASC-H Vs HSIL: Nuclear abnormalities such as hyperchromasia,
chromatin irregularity and abnormal nuclear shapes with focal
irregularity favor an interpretation of HSIL.
ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL
(ASC-H)
46
47. B. Crowded Sheet Pattern:
• Dense cytoplasm, polygonal cell shape and fragments with
sharp linear edges generally favor squamous over
glandular (endocervical) differentiation.
C. ASC-H Mimics:
• Isolated endocervical cells
• Degenerated endometrial cells
• Macrophages
• IUD: may shed rare cells with high N:C ratio
• Pregnancy and post-partum: atypical appearing
decidualized stromal cells
ATYPICAL SQUAMOUS CELL –CANNOT EXCLUDE HSIL
(ASC-H)
47
49. • CRITERIA
– Cells occur singly, in clusters, and in sheets
– Cytological changes are usually confined to
squamous cells with ‘mature’ intermediate or
superficial squamous cell- type cytoplasm
– Overall cell size is large, with fairly abundant
‘mature’ well-defined cytoplasm
– Nuclear enlargement more than 3 times the area of
normal intermediate nuclei results in a low but
slightly increased N:C ratio
Low-grade Squamous Intraepithelial Lesion (LSIL)
49
50. • CRITERIA
– Nuclei are generally hyperchromatic but may be
normochromatic
– Nuclei show variable size (anisonucleosis)
– Chromatin is uniformly distributed and ranges from
coarsely granular to smudgy or densely opaque
– Contour of nuclear membranes is variable ranging
from smooth to very irregular with notches
– Binucleation and multinucleation are common
– Nucleoli are generally absent or inconspicuous if
present
Low-grade Squamous Intraepithelial Lesion (LSIL)
50
51. • CRITERIA
– Koilocytosis or perinuclear cavitation consisting of a
broad, sharply delineated clear peri-nuclear zone and a
peripheral rim of densely stained cytoplasm is a
characteristic viral cytopathic feature but is not required
for the interpretation of LSIL
– Cells may show increased keratinization with dense,
eosinophilic cytoplasm with little or no evidence of
koilocytosis
– Cells with koilocytosis or dense orangeophilia must also
show nuclear abnoramalities to be diagnostic of LSIL,
perinuclear halos in the absence of nuclear
abnormalities does not qualify for the interpretation of
LSIL
Low-grade Squamous Intraepithelial Lesion (LSIL)
51
58. • CRITERIA
– Cells occur singly, in sheets, or in syncytial aggregates
– Smaller and show less cytoplasmic maturity than cells of
LSIL
– Syncytial aggregates of dysplastic cells may result in
hyperchromatic crowded groups
– Overall cell size is variable, in general, the cells of HSIL
are smaller than those of LSIL. Higher-grade lesions often
contain quite small basal-type cells
– Degree of nuclear enlargement is more variable than
that seen in LSIL. Even if nucleus size is same as that of
LSIL, cytoplasmic area is decreased leading to marked
increase in N:C ratio.
High-grade Squamous Intraepithelial Lesion (HSIL)
58
59. • CRITERIA
– Nuclei are generally hyperchromatic but may be
normochromatic or even hypochromatic
– Chromatin may be fine or coarsely granular and is evenly
distributed
– Contour of the nuclear membrane is quite irregular and
frequently demonstrates prominent indentations or
grooves
– Nucleoli are generally absent, but may occasionally be
seen, particularly when HSIL extends into endocervical
gland spaces or in the background of reactive or
reparative changes
– Cytoplasm: variable; immature, lacy or delicate or
densely metaplastic ; mature and densely keratinized as
in keratinizing HSIL.
High-grade Squamous Intraepithelial Lesion (HSIL)
59
61. • Syncytial Aggregates/ Hyperchromatic Crowded
Groups:
• SIL with Endocervical Gland Involvement
• Endometrial cells or Squamous Repair
• Keratinizing High Grade Lesion
• HSIL in Atrophy
• LSIL with some features suggestive of concurrent
HSIL
Problematic Pattern in HSIL
61
62. Note the flattening of cells at the edge of cluster.
SIL with EC gland involvement
62
63. • Isolated cells
Reserve cells
Parabasal cells
Immature sq. met. cells
• Histiocytes or Lymphocytes
Kidney shaped
Nuclear membrane
notching and irregularity
is absent
• Decidualized Stromal cells
History of pregnancy, more
granular but less dense
cytoplasm, prominent
nucleoli.
Mimics of HSIL
63
67. • Definition:
–WHO, 2014: SCC is an invasive epithelial
tumor composed of squamous cells of
varying degrees of differentiation
Keratinizing vs Non-keratinizing SCC
The Bethesda system doesnot subdivide
squamous cell carcinoma per se.
Squamous Cell Carcinoma
67
68. • CRITERIA:
– Presents predominantly as isolated, single cells and
less commonly in cellular aggregates
– Marked variation in cellular size and shape is typical,
with caudate and spindle cells that frequently
contain dense orangeophilic cytoplasm
– Nuclei vary markedly in area, nuclear membranes
may be irregular, and numerous dense opaque nuclei
are often present
– Chromatin pattern, when discernible, is coarsely
granular and irregularly distributed with chromatin
clearing
Squamous Cell Carcinoma KERATINIZING
68
69. • CRITERIA:
– Macronucleoli may be seen but are less common in
NKSCC
– As keratotic changes (hyper or para) may be present
but are not sufficient for the interpretation of
carcinoma in the absence of nuclear abnormalities
– A tumor diasthesis may be present but is usually less
than that seen in NKSCC
Squamous Cell Carcinoma KERATINIZING
69
71. • CRITERIA:
– Cells occur singly or in syncytial aggregates with
poorly defined cell borders
– Cells may be somewhat smaller than those of many
HSIL, but display most of the features of HSIL
– Nuclei demonstrate markedly irregular distribution
of coarsely clumped chromatin with chromatin
clearing
– Nucleoli may be prominent
– A tumor diasthesis consisting of necrotic debris and
broken-down elements is often present
Squamous Cell Carcinoma NON-KERATINIZING
71
73. 1. The Bethesda System of Reporting Cervical
Cytopathology, 3rd edition, 2014
2. The Bethesda System and Beyond, BD
Surepath
3. Robbins and Cotran Pathological Basis of
Disease, 9th edition, 2015
4. Uptodate, 2019
5. www.ncbi.nlm.nih.gov/pubmed
REFERENCES:
73